{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:23:21Z","timestamp":1787657001953,"version":"build-2736575974"},"reference-count":302,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>C-reactive protein (CRP) is a widely used biomarker of systemic inflammation and cardiovascular risk. Its clinical and experimental relevance has been investigated across major cardiovascular disease (CVD) phenotypes, including coronary artery disease, heart failure, arrhythmias, cardiomyopathies, hypertension, and aortic aneurysm. High-sensitivity CRP (hs-CRP) assays detect low-grade systemic inflammation, and elevated circulating hs-CRP is associated with incident cardiovascular events, recurrent events, and mortality. CRP also exhibits conformation-dependent biological properties. Circulating pentameric CRP (pCRP) can undergo transition through modified pentameric CRP (pCRP*) to monomeric CRP (mCRP) at activated or damaged membranes. Experimental studies indicate that pCRP* and mCRP may exert localized effects on endothelial cells, vascular smooth muscle cells, immune cells, complement activation, coagulation, and extracellular matrix remodeling. However, observational, genetic, animal, and interventional evidence does not establish circulating CRP as a major independent cause of CVD, and the causal and clinical significance of tissue-associated CRP conformations remains unresolved. Clinically, hs-CRP- and CRP-based composite indices may support risk stratification and assessment of residual inflammatory risk, although their performance and thresholds vary across populations and clinical settings. Upstream anti-inflammatory and metabolic therapies can lower circulating CRP indirectly, whereas CRP apheresis, anti-CRP antibodies, and inhibitors of conformational transition are direct CRP-directed approaches that remain investigational. This review synthesizes clinical, structural, mechanistic, and therapeutic evidence for CRP across major CVD phenotypes and identifies priorities for conformation-specific measurement, causal evaluation, and target-specific intervention. At present, hs-CRP is principally a biomarker of inflammatory risk, whereas the therapeutic value of directly targeting CRP remains to be established.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1924339","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:04:05Z","timestamp":1787655845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["C-reactive protein in cardiovascular disease: clinical associations, conformation-dependent biology, and therapeutic perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Bingxing","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiac Electrophysiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Basic Research in Traditional Chinese Medicine, Hunan Academy of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Cardiometabolic Science, University of Louisville","place":["Louisville, KY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Mathematics, College of Science, City University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqing","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-025-01285-y","article-title":"Circulating inflammation-related proteome improves cardiovascular risk prediction. Results from two large european cohort studies","volume":"40","author":"Xie","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.hlc.2020.09.003","article-title":"Combating inflammation in cardiovascular disease","volume":"30","author":"Sethwala","year":"2021","journal-title":"Heart Lung Circ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020922994","article-title":"The role of suppressing inflammation in the treatment of atherosclerotic cardiovascular disease","volume":"54","author":"Roman","year":"2020","journal-title":"Ann Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vph.2015.05.001","article-title":"Biological actions of pentraxins","volume":"73","author":"Vilahur","year":"2015","journal-title":"VascPharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.18433\/jpps29872","article-title":"The use of high sensitivity C-reactive protein in cardiovascular disease detection","volume":"21","author":"Castro","year":"2018","journal-title":"J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/1440-1681.12758","article-title":"C-reactive protein and ageing","volume":"44","author":"Tang","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119129","article-title":"C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional mendelian randomization study","volume":"24","author":"Kuppa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-024-02207-0","article-title":"Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and mendelian randomization studies","volume":"23","author":"Rolver","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01302","article-title":"The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14188","article-title":"Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites","volume":"8","author":"Braig","year":"2017","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/319215","article-title":"Recognition functions of pentameric C-reactive protein in cardiovascular disease","volume":"2014","author":"Agrawal","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032079","article-title":"Monomeric C-reactive protein in atherosclerotic cardiovascular disease: advances and perspectives","volume":"24","author":"Melnikov","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-024-02055-7","article-title":"The predictive value of the hs-CRP\/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study","volume":"23","author":"Gao","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","article-title":"The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS)","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2025.07.009","article-title":"Cardiometabolic effects of GLP-1 analogs in obese and overweight patients with preexisting cardiovascular disease: a systematic review and meta analysis of randomized controlled trials","volume":"74","author":"Natali","year":"2025","journal-title":"Heart Lung"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.01.029","article-title":"Prognostic value of suPAR and hs-CRP on cardiovascular disease","volume":"271","author":"Diederichsen","year":"2018","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ahj.2015.04.017","article-title":"Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality","volume":"170","author":"Parrinello","year":"2015","journal-title":"Am Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/561428","article-title":"C-reactive protein in human atherogenesis: facts and fiction","volume":"2014","author":"Zimmermann","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2009.07.005","article-title":"Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander","volume":"19","author":"Nordestgaard","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e32836411d6","article-title":"C-reactive protein and subclinical cardiovascular disease among african-americans: (the jackson heart study)","volume":"15","author":"Sung","year":"2014","journal-title":"J Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.accreview.2005.10.016","article-title":"Race and gender differences in C-reactive protein levels","volume":"14","author":"Khera","year":"2005","journal-title":"Acc Curr J Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237729","article-title":"C-reactive protein: a target for therapy to reduce inflammation","volume":"14","author":"Rizo-T\u00e9llez","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/srep31979","article-title":"Influence of elevated-CRP level-related polymorphisms in non-rheumatic caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis","volume":"6","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.103814","article-title":"Associations of the hs-CRP\/HDL-C ratio with cardiovascular disease among US adults: evidence from NHANES 2015-2018","volume":"35","author":"Li","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.09.028","article-title":"CRP after 2004","volume":"42","author":"Agrawal","year":"2005","journal-title":"Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00943","article-title":"Evolution of C-reactive protein","volume":"10","author":"Pathak","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-102","article-title":"CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool","volume":"7","author":"Coventry","year":"2009","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1564607","article-title":"Redefining CRP in tissue injury and repair: more than an acute pro-inflammatory mediator","volume":"16","author":"Potempa","year":"2025","journal-title":"Front Immunol"},{"key":"B31","unstructured":"C-reactive protein: clinical relevance and interpretation\n          \n          \n            \n              Singh\n              B\n            \n            \n              Goyal\n              A\n            \n            \n              Patel\n              BC\n            \n          \n          Treasure Island (FL\n          StatPearls Publishing\n          \n          2026"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab314","article-title":"Mol* viewer: modern web app for 3D visualization and analysis of large biomolecular structures","volume":"49","author":"Sehnal","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/0929866522666141231111226","article-title":"A staggered decameric assembly of human C-reactive protein stabilized by zinc ions revealed by X-ray crystallography","volume":"22","author":"Guillon","year":"2015","journal-title":"Protein Pept Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203181","article-title":"Human CRP defends against the toxicity of circulating histones","volume":"191","author":"Abrams","year":"2013","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1466865","article-title":"An evolutionarily conserved function of C-reactive protein is to prevent the formation of amyloid fibrils","volume":"15","author":"Agrawal","year":"2024","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2174\/187152910793743841","article-title":"Atherosclerosis-related functions of C-reactive protein","volume":"10","author":"Agrawal","year":"2010","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24112062","article-title":"The multiple faces of C-reactive protein-physiological and pathophysiological implications in cardiovascular disease","volume":"24","author":"Boncler","year":"2019","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02422-7","article-title":"Characterizing CRP dynamics during acute infections","volume":"53","author":"Cherny","year":"2025","journal-title":"Infection"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000096055.62724.C5","article-title":"Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells","volume":"108","author":"Calabr\u00f3","year":"2003","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61202-3","article-title":"C-reactive protein in atherosclerotic lesions","volume":"167","author":"Sun","year":"2005","journal-title":"Am J Pathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.113.007124","article-title":"Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: In vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy","volume":"130","author":"Thiele","year":"2014","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2016(04)11","article-title":"High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities","volume":"71","author":"Fonseca","year":"2016","journal-title":"Clinics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.012","article-title":"C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk","volume":"50","author":"Hage","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-021-10035-0","article-title":"The association of IL-6, TNF\u03b1 and CRP gene polymorphisms with coronary artery disease in a Tunisian population: a case\u2013control study","volume":"59","author":"Grira","year":"2021","journal-title":"Biochem Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12872-022-02610-z","article-title":"CRP levels are significantly associated with CRP genotype and estrogen use in the lifestyle, biomarker and atherosclerosis (LBA) study","volume":"22","author":"Frans\u00e9n","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01780","article-title":"Conformationally altered C-reactive protein capable of binding to atherogenic lipoproteins reduces atherosclerosis","volume":"11","author":"Pathak","year":"2020","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2023-0127","article-title":"C-reactive protein accelerates DRP1-mediated mitochondrial fission by modulating ERK1\/2-YAP signaling in cardiomyocytes","volume":"56","author":"Jin","year":"2023","journal-title":"BMB Rep"},{"key":"B49","article-title":"Effect of CRP on some of the in vitro physicochemical properties of LDL","volume":"6","author":"Nayeri","year":"2010","journal-title":"ARYA Atheroscler"},{"key":"B50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","article-title":"Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study","volume":"24","author":"Sun","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.10.002","article-title":"Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome","volume":"400","author":"Wetter\u00f6","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-016-9678-0","article-title":"Plasma levels of endothelial microparticles bearing monomeric C-reactive protein are increased in peripheral artery disease","volume":"9","author":"Crawford","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00511","article-title":"An ELISA assay for quantifying monomeric C-reactive protein in plasma","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1556\/ABiol.65.2014.3.3","article-title":"Immunohistochemical staining reveals C-reactive protein existing predominantly as altered conformation forms in inflammatory lesions","volume":"65","author":"Shi","year":"2014","journal-title":"Acta Biol Hung"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d548","article-title":"Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data","volume":"342","year":"2011","journal-title":"BMJ"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.161414","article-title":"No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice","volume":"286","author":"Teupser","year":"2011","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706027104","article-title":"Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia","volume":"104","author":"Kovacs","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120594","article-title":"C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin","volume":"412","author":"Fu","year":"2026","journal-title":"Atherosclerosis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216446","article-title":"Sustainability of C-reactive protein apheresis in acute myocardial infarction\u2014results from a supplementary data analysis of the exploratory C-reactive protein in acute myocardial infarction-1 study","volume":"11","author":"Skarabis","year":"2022","journal-title":"J Clin Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2025.07.067","article-title":"Selective C-reactive protein apheresis in ST-elevation myocardial infarction: design and rationale of the randomized CRP-STEMI trial","volume":"291","author":"Reinstadler","year":"2026","journal-title":"Am Heart J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-022-00911-x","article-title":"CRP apheresis in acute myocardial infarction and COVID-19","volume":"117","author":"Buerke","year":"2022","journal-title":"Med Klin Intensivmed Notfallmedizin"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176338","article-title":"Hegemony of inflammation in atherosclerosis and coronary artery disease","volume":"966","author":"Attiq","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2026.103261","article-title":"The critical role of inflammation in atherosclerotic coronary artery heart disease","volume":"51","author":"Spindler","year":"2026","journal-title":"Curr Probl Cardiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150420124427","article-title":"Novel inflammatory biomarkers in coronary artery disease: potential therapeutic approaches","volume":"22","author":"Voudris","year":"2015","journal-title":"Curr Med Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.cir.100.1.96","article-title":"C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon","volume":"100","author":"Lagrand","year":"1999","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/genes14051073","article-title":"Analysis of the effects of IL-6 -572 C\/G, CRP -757 a\/G, and CRP -717 T\/C gene polymorphisms; IL-6 levels; and CRP levels on chronic periodontitis in coronary artery disease in Indonesia","volume":"14","author":"Sitompul","year":"2023","journal-title":"Genes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001131","article-title":"Genetic association studies reporting on variants in the C-reactive protein gene and coronary artery disease: a meta-analysis","volume":"94","author":"Shi","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.01.010","article-title":"Paraoxonase-1 Q192R polymorphism and its association with hs-CRP and fasting blood glucose levels and risk of coronary artery disease","volume":"13","author":"Amini","year":"2019","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2019-136917","article-title":"Effects of ABCA1 gene polymorphisms on risk factors, susceptibility and severity of coronary artery disease","volume":"96","author":"Lu","year":"2020","journal-title":"Postgrad Med J"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1177\/10760296241234320","article-title":"Triglyceride-glucose index as a valuable marker to predict severity of coronary artery disease: a retrospective cohort study","volume":"30","author":"Geng","year":"2024","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2017.02.035","article-title":"High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease","volume":"190","author":"Sara","year":"2017","journal-title":"Am Heart J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1532\/hsf.2397","article-title":"Association of uric acid and C-reactive protein with the severity of coronary artery disease using SYNTAX score and clinical SYNTAX score","volume":"22","author":"Xing","year":"2019","journal-title":"Heart Surg Forum"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27945","article-title":"Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors","volume":"234","author":"Tajfard","year":"2019","journal-title":"J Cell Physiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.946897","article-title":"Relationship between CRP\/ALB ratio and severity of coronary artery lesions in hypertensive patients with acute myocardial infarction","volume":"31","author":"Lou","year":"2025","journal-title":"Med Sci Monit"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22457","article-title":"Relationship between C-reactive protein\/albumin ratio and coronary artery disease severity in patients with stable angina pectoris","volume":"32","author":"Karaba\u011f","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"B77","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12872-024-04014-7","article-title":"The evaluation value of atherogenic index of plasma and high-sensitivity C-reactive protein for the degree of coronary artery lesion in premature coronary artery disease","volume":"24","author":"Song","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1836149","article-title":"Association of the hs-CRP-TyG index with coronary artery disease risk and angiographic severity: a retrospective comparative study with the TyG index","volume":"17","author":"Yang","year":"2026","journal-title":"Front Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00504-6","article-title":"Utility of inflammatory markers in the management of coronary artery disease","volume":"92","author":"Rosenson","year":"2003","journal-title":"Am J Cardiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2015.03.029","article-title":"Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the taichung CAD study)","volume":"445","author":"Pan","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000604","article-title":"Baseline high-sensitivity C-reactive protein as a predictor of adverse clinical events in patients with coronary artery disease undergoing percutaneous coronary intervention: a meta-analysis","volume":"33","author":"Yang","year":"2025","journal-title":"Cardiol Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2014.02.003","article-title":"Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy","volume":"15","author":"Ndrepepa","year":"2014","journal-title":"Cardiovasc Revasc Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.5551\/jat.64047","article-title":"Impact of C-reactive protein on long-term cardiac events in stable coronary artery disease patients with chronic kidney disease","volume":"30","author":"Tokuda","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"B84","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.accreview.2003.08.041","article-title":"Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency","volume":"12","author":"Zebrack","year":"2003","journal-title":"Acc Curr J Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.1316","article-title":"Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease","volume":"72","author":"Dai","year":"2008","journal-title":"Circ J"},{"key":"B86","article-title":"Combination of high-sensitivity C-reactive protein and homocysteine may predict an increased risk of coronary artery disease in korean population","volume":"125","author":"Cho","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X13666170426104611","article-title":"The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature","volume":"13","author":"Diamantis","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000001148","article-title":"Effect of different doses of atorvastatin on collateral formation in coronary artery disease patients with coronary atherosclerosis","volume":"33","author":"Liu","year":"2022","journal-title":"Coron Artery Dis"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.07.074","article-title":"Early effects of statins in patients with coronary artery disease and high C-reactive protein","volume":"94","author":"Muhlestein","year":"2004","journal-title":"Am J Cardiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ahj.2011.12.017","article-title":"Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis","volume":"163","author":"Swardfager","year":"2012","journal-title":"Am Heart J"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10024-1409","article-title":"The effects of phase III cardiac rehabilitation in serum and salivary Hs-CRP and anthropometric measurements in patients with coronary artery disease","volume":"14","author":"Mirzaii-Dizgah","year":"2013","journal-title":"J Contemp Dent Pract"},{"key":"B95","article-title":"The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients","volume":"15","author":"Fabijani\u0107","year":"2009","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12944-025-02627-1","article-title":"Concordant and discordant roles of remnant cholesterol and hs-CRP in cardiovascular disease; gender stratified analysis","volume":"24","author":"Kamrani","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141117","article-title":"The role of inflammation in the pathophysiology of heart failure","volume":"14","author":"Amara","year":"2025","journal-title":"Cells"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-025-10519-w","article-title":"A comprehensive review: unraveling the role of inflammation in the etiology of heart failure","volume":"30","author":"Roman-Pepine","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.17219\/dmp\/210102","article-title":"Smoldering inflammation: the silent flame driving heart failure","volume":"62","author":"Wilk","year":"2025","journal-title":"Dent Med Probl"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.036","article-title":"The evolving role of C-reactive protein in heart failure: implications for patients with cardiovascular disease","volume":"82","author":"Jialal","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12756","article-title":"Biomarkers for heart failure: small molecules with high clinical relevance","volume":"283","author":"Magnussen","year":"2018","journal-title":"J Intern Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ Heart Failure"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2024.03.018","article-title":"Low-density neutrophils and neutrophil extracellular traps (NETs) are new inflammatory players in heart failure","volume":"40","author":"Dumont","year":"2024","journal-title":"Can J Cardiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1900026","article-title":"CRP induces NETosis in heart failure patients with or without diabetes","volume":"3","author":"Vulesevic","year":"2019","journal-title":"ImmunoHorizons"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1544823","article-title":"Metabolic syndrome, high-sensitivity C-reactive protein and the risk of heart failure: the kailuan cohort study","volume":"16","author":"Tian","year":"2025","journal-title":"Front Endocrinol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11463","article-title":"Association between inflammatory markers and myocardial fibrosis: the MESA","volume":"72","author":"Marques","year":"2018","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063169","article-title":"C-reactive protein as a risk marker for post-infarct heart failure over a multi-year period","volume":"22","author":"\u015awi\u0105tkiewicz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030807","article-title":"Enhanced inflammation is a marker for risk of post-infarct ventricular dysfunction and heart failure","volume":"21","author":"\u015awi\u0105tkiewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14959","article-title":"IL-6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction","volume":"11","author":"Berger","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202201_27868","article-title":"Relationship between polymorphism rs2794521 in CRP gene and survival of depressive patients with chronic heart failure","volume":"26","author":"Opielak","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.04.002","article-title":"CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients","volume":"71","author":"Kittel-Schneider","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.11.003","article-title":"C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: heart and soul study","volume":"10","author":"Williams","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-reactive protein and risk of incident heart failure in patients with cardiovascular disease","volume":"82","author":"Burger","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001373","article-title":"Inflammation and heart failure: a two-sample mendelian randomization study","volume":"23","author":"Remmelzwaal","year":"2022","journal-title":"J Cardiovasc Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12872-023-03149-3","article-title":"Effect of C-reactive protein on the risk of heart failure: a mendelian randomization study","volume":"23","author":"Habibi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B118","article-title":"Significances of NT-proBNP and hs-CRP in heart failure","volume":"90","author":"Wang","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B119","article-title":"Neutrophil-lymphocyte ratio and high sensitivity C-reactive protein as markers of heart failure severity: a study at the university of port-harcourt teaching hospital heart failure clinic","volume":"41","author":"Ajala","year":"2024","journal-title":"West Afr J Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12872-025-04985-1","article-title":"A nomogram for predicting malnutrition risk in patients with chronic heart failure and correlation study between GHRL, MSTN, CRP, Hs-CRP","volume":"25","author":"Zha","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202012_24186","article-title":"Correlation between growth differentiation factor-15 and the severity of chronic heart failure in patients with coronary atherosclerosis","volume":"24","author":"Du","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20812","article-title":"Higher C-reactive protein predicts worse prognosis in acute heart failure only in noninfected patients","volume":"33","author":"Louren\u00e7o","year":"2010","journal-title":"Clin Cardiol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156053","article-title":"Interleukin-6, infection and cardiovascular outcomes in acute heart failure: findings from the EDIFICA registry","volume":"160","author":"Vasques-N\u00f3voa","year":"2022","journal-title":"Cytokine"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11897-022-00584-9","article-title":"C-reactive protein, interleukin-6, trimethylamine-N-oxide, syndecan-1, nitric oxide, and tumor necrosis factor receptor-1 in heart failure with preserved versus reduced ejection fraction: a meta-analysis","volume":"20","author":"Gui","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-022-02090-3","article-title":"Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction","volume":"37","author":"Watanabe","year":"2022","journal-title":"Heart Vessels"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116090","article-title":"Advances in heart failure monitoring: biosensors targeting molecular markers in peripheral bio-fluids","volume":"255","author":"Dong","year":"2024","journal-title":"Biosens Bioelectron"},{"key":"B127","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12967-025-06563-7","article-title":"Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes","volume":"23","author":"Karuna","year":"2025","journal-title":"J Transl Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157159","article-title":"Multi-marker strategy in heart failure: combination of ST2 and CRP predicts poor outcome","volume":"11","author":"Dupuy","year":"2016","journal-title":"PloS One"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.110","article-title":"Biomarkers for characterization of heart failure - distinction of heart failure with preserved and reduced ejection fraction","volume":"227","author":"Sinning","year":"2017","journal-title":"Int J Cardiol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13019-023-02176-7","article-title":"Diagnostic value of echocardiography combined with serum C-reactive protein level in chronic heart failure","volume":"18","author":"Zhang","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1177\/00033197251338416","article-title":"Association between the C-reactive protein-albumin-lymphocyte (CALLY) index and length of hospital stay in patients with heart failure","volume":"77","author":"Candemir","year":"2026","journal-title":"Angiology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102475","article-title":"The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: a systematic review","volume":"49","author":"Kurniawan","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084099","article-title":"Relationship between the HDL-C\/CRP ratio and all-cause mortality in patients with chronic heart failure: a retrospective analysis from yunnan province, China","volume":"15","author":"Liuzhuang","year":"2025","journal-title":"BMJ Open"},{"key":"B134","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12872-025-05460-7","article-title":"Prognostic value of the CRP-TyG index for in-hospital and 1-year mortality in patients with decompensated heart failure","volume":"26","author":"Kaya","year":"2026","journal-title":"BMC Cardiovasc Disord"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure: prognostic value and the effect of valsartan","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09927-x","article-title":"Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"26","author":"Lakhani","year":"2021","journal-title":"Heart Fail Rev"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041068","article-title":"C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study","volume":"10","author":"Nishimoto","year":"2020","journal-title":"BMJ Open"},{"key":"B138","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","article-title":"Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the bio-SHiFT study","volume":"196","author":"van Boven","year":"2018","journal-title":"Am Heart J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(02)00021-1","article-title":"C-reactive protein as a predictor of improvement and readmission in heart failure","volume":"4","author":"Alonso-Mart\u00ednez","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112744","article-title":"Long-term prognostic value of CRP\u2013albumin\u2013lymphocyte index in elderly patients with heart failure with preserved ejection fraction","volume":"204","author":"He","year":"2025","journal-title":"Exp Gerontol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.amjcard.2021.11.018","article-title":"C-reactive protein and frailty in heart failure","volume":"166","author":"Ribeiro","year":"2022","journal-title":"Am J Cardiol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40520-024-02713-x","article-title":"Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis","volume":"36","author":"Prokopidis","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3349","article-title":"Incremental value of C-reactive protein to the MEESSI acute heart failure risk score","volume":"26","author":"Wussler","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-017-1195-x","article-title":"Systemic inflammation and functional capacity in elderly heart failure patients","volume":"107","author":"Radenovic","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.jchf.2024.12.012","article-title":"Interleukin-6 in heart failure with reduced ejection fraction and the effect of dapagliflozin: an exploratory analysis of the dapagliflozin and prevention of adverse outcomes in heart failure trial","volume":"13","author":"Docherty","year":"2025","journal-title":"JACC Heart Fail"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2025-0011","article-title":"The real-world anti-inflammatory effect of SGLT2i in patients with chronic heart failure","volume":"18","author":"Arvunescu","year":"2025","journal-title":"J Med Life"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-025-10491-5","article-title":"Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis","volume":"30","author":"Davison","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am J Cardiol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/medsci11010004","article-title":"Anakinra in heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Mahfooz","year":"2022","journal-title":"Med Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13926","article-title":"Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C-reactive protein","volume":"9","author":"Mir\u00f3","year":"2022","journal-title":"ESC Heart Fail"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1000307","article-title":"Predicting therapeutic response in patients with heart failure: the story of C-reactive protein","volume":"13","author":"Huynh","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-018-9677-0","article-title":"Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis","volume":"23","author":"Pearson","year":"2018","journal-title":"Heart Fail Rev"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-023-10327-0","article-title":"Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis","volume":"28","author":"Prokopidis","year":"2023","journal-title":"Heart Fail Rev"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2024.09.003","article-title":"Multidisciplinary cardiorenal program for heart failure patients: improving outcomes through comprehensive care","volume":"44","author":"Cal\u00e7a","year":"2025","journal-title":"Rev Port Cardiol Orgao Soc Port Cardiol = Port J Cardiol Off J Port Soc Cardiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12916-023-02770-5","article-title":"Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: evidence from the UK biobank cohort","volume":"21","author":"Yang","year":"2023","journal-title":"BMC Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euag067","article-title":"Inflammation and day-to-day occurrence of atrial fibrillation","volume":"28","author":"Hessellund","year":"2026","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2174\/0929867324666171012105528","article-title":"Biomarkers of atrial fibrillation in metabolic syndrome","volume":"26","author":"Georgakopoulos","year":"2019","journal-title":"Curr Med Chem"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.07.022","article-title":"Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease","volume":"248","author":"Nortamo","year":"2017","journal-title":"Int J Cardiol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2013.08.078","article-title":"Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis","volume":"169","author":"Wu","year":"2013","journal-title":"Int J Cardiol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1080\/00365510802676848","article-title":"Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion","volume":"69","author":"Henningsen","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2007.00198.x","article-title":"High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis","volume":"13","author":"Ucer","year":"2008","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2023.11.009","article-title":"Association of C-reactive protein level with adverse outcomes in patients with atrial fibrillation: a meta-analysis","volume":"367","author":"Zhang","year":"2024","journal-title":"Am J Med Sci"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.05.051","article-title":"Inflammation and risk of cardiovascular outcomes in patients with atrial fibrillation and flutter: a nationwide registry study","volume":"23","author":"Langhoff","year":"2026","journal-title":"Heart Rhythm"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190888","article-title":"C-reactive protein promotes inflammation through TLR4\/NF-\u03baB\/TGF-\u03b2 pathway in HL-1 cells","volume":"39","author":"Sun","year":"2019","journal-title":"Biosci Rep"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231165055","article-title":"Interrelationship between inflammatory biomarkers and collagen remodeling proteins in atrial fibrillation","volume":"29","author":"Odeh","year":"2023","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.231","article-title":"Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects","volume":"23","author":"Tsioufis","year":"2010","journal-title":"Am J Hypertens"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102655","article-title":"Continuous positive airway pressure effectively ameliorates arrhythmias in patients with obstructive sleep apnea-hypopnea via counteracting the inflammation","volume":"41","author":"Wang","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000255","article-title":"Meta-analysis identifies serum C-reactive protein as an indicator of atrial fibrillation risk after coronary artery bypass graft","volume":"23","author":"Li","year":"2016","journal-title":"Am J Ther"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.5603\/KP.a2017.0242","article-title":"Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis","volume":"76","author":"Weymann","year":"2018","journal-title":"Kardiol Pol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"494","DOI":"10.25122\/jml-2025-0085","article-title":"Inflammatory biomarkers for predicting postoperative atrial fibrillation in cardiac surgery","volume":"18","author":"Staicu","year":"2025","journal-title":"J Med Life"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa088","article-title":"C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation","volume":"22","author":"Olesen","year":"2020","journal-title":"EP Eur"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038882","article-title":"Catheter ablation of atrial fibrillation in patients with psoriasis: a multicenter study","volume":"14","author":"Compagnucci","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22157","article-title":"Association between C-reactive protein and atrial fibrillation recurrence after catheter ablation: a meta-analysis","volume":"36","author":"Jiang","year":"2013","journal-title":"Clin Cardiol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004418","article-title":"Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis","volume":"4","author":"Yo","year":"2014","journal-title":"BMJ Open"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2008.01155.x","article-title":"Protracted CRP elevation after atrial fibrillation ablation","volume":"31","author":"McCABE","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1080\/17520363.2024.2395236","article-title":"Comparison of inflammatory markers for the prediction of atrial fibrillation recurrence following cryoablation","volume":"18","author":"Kalenderoglu","year":"2024","journal-title":"Biomarkers Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.03.1958","article-title":"Nonlinear relationship and predictive value of systemic immune-inflammation index for atrial fibrillation recurrence after catheter ablation in hypertensive patients","volume":"22","author":"Zhang","year":"2025","journal-title":"Heart Rhythm"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2024.04.017","article-title":"Associations between biomarkers of myocardial injury and systemic inflammation and risk of incident ventricular arrhythmia","volume":"10","author":"Sourour","year":"2024","journal-title":"JACC: Clin Electrophysiol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jelectrocard.2020.07.005","article-title":"Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19","volume":"62","author":"Yener\u00e7a\u011f","year":"2020","journal-title":"J Electrocardiol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-021-01033-8","article-title":"QTc interval prolongation, inflammation, and mortality in patients with COVID-19","volume":"63","author":"Gulletta","year":"2022","journal-title":"J Interv Card Electrophysiol Int J Arrhythm Pacing"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027247","article-title":"Inflammation and incident conduction disease","volume":"12","author":"Frimodt-M\u00f8ller","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/402481","article-title":"Atorvastatin treatment for atrial fibrillation reduces serum high-sensitivity C-reactive protein levels","volume":"2015","author":"Su","year":"2015","journal-title":"BioMed Res Int"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1177\/1074248415602557","article-title":"Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials","volume":"21","author":"Rezaei","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B190","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s13054-016-1560-6","article-title":"Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"20","author":"Putzu","year":"2016","journal-title":"Crit Care"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"B192","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107759","article-title":"Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator","volume":"216","author":"Sardu","year":"2025","journal-title":"Pharmacol Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03225-1","article-title":"Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial","volume":"397","author":"Zarei","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.08.023","article-title":"Atrial fibrillation and semaglutide effects in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2022.03.008","article-title":"C-reactive protein and atrial fibrillation: insights from epidemiological and mendelian randomization studies","volume":"32","author":"Li","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0528","article-title":"C-reactive protein (CRP) is not a mere marker, but an active pathogenic substance","volume":"75","author":"Miura","year":"2011","journal-title":"Circ J"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.3.221","article-title":"Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease","volume":"2","author":"Osman","year":"2006","journal-title":"Vasc Healt Risk Manage"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2025.2528001","article-title":"Inflammatory cardiomyopathy: a comprehensive review of biomarkers and future therapeutic perspectives","volume":"80","author":"Chitroda","year":"2025","journal-title":"Acta Cardiol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.06.040","article-title":"The clinicopathologic features of fulminant myocarditis","volume":"81","author":"Cui","year":"2026","journal-title":"J Adv Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014697","article-title":"Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: a meta-analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2512645","article-title":"A review of immune checkpoint inhibitor-associated myocarditis: epidemiology, pathogenesis, and biomarkers","volume":"21","author":"Xu","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133104","article-title":"Diagnostic value of ROCK2 protein in immune checkpoint inhibitors-associated myocarditis","volume":"427","author":"Li","year":"2025","journal-title":"Int J Cardiol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1177\/02841851211046502","article-title":"COVID-19 myocarditis cardiac magnetic resonance findings in symptomatic patients","volume":"63","author":"Altay","year":"2022","journal-title":"Acta Radiol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hcac064","article-title":"Myocarditis post-SARS-CoV-2 vaccination: a systematic review","volume":"116","author":"Goyal","year":"2023","journal-title":"QJM: Mon J Assoc Physicians"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23965","article-title":"Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: a systematic review","volume":"46","author":"Fatima","year":"2023","journal-title":"Clin Cardiol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000088138","article-title":"C-reactive protein predicts death in patients with non-ischemic cardiomyopathy","volume":"104","author":"Ronnow","year":"2005","journal-title":"Cardiology"},{"key":"B209","first-page":"395","article-title":"C-reactive protein (CRP) in the cardiovascular system","volume":"49","author":"Kanda","year":"2001","journal-title":"Rinsho Byori Jpn J Clin Pathol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216610","article-title":"High serum CRP influences myocardial miRNA profiles in ischemia-reperfusion injury of rat heart","volume":"14","author":"Kim","year":"2019","journal-title":"PloS One"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.040600","article-title":"C-reactive-protein-associated increase in myocardial infarct size after ischemia\/reperfusion","volume":"303","author":"Barrett","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivx107","article-title":"The effect of C-reactive protein deposition on myocardium with ischaemia\u2013reperfusion injury in rats","volume":"25","author":"Oh","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-67","article-title":"Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"B214","doi-asserted-by":"publisher","first-page":"18889","DOI":"10.1038\/s41598-023-46338-y","article-title":"Exploring the diagnostic and prognostic value of the C-reactive protein\/lymphocyte ratio for dilated cardiomyopathy based on a real-world study","volume":"13","author":"Qi","year":"2023","journal-title":"Sci Rep"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020871","article-title":"Diagnostic and prognostic utility of DNI and CRP in patients with dilated cardiomyopathy","volume":"27","author":"S\u00f6ylemez","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-1199","article-title":"Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy","volume":"75","author":"Mano","year":"2011","journal-title":"Circ J"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.04.149","article-title":"Head-to-head comparison of 2 inflammatory biomarkers for the long-term prediction of left ventricular diastolic dysfunction in type 2 diabetes patients: soluble ST2 versus hs-CRP","volume":"174","author":"Fousteris","year":"2014","journal-title":"Int J Cardiol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0509","article-title":"Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial","volume":"40","author":"Ohkuma","year":"2017","journal-title":"Diabetes Care"},{"key":"B219","doi-asserted-by":"publisher","first-page":"28","DOI":"10.36628\/ijhf.2023.0033","article-title":"C-reactive protein can predict outcomes in patients with takotsubo syndrome","volume":"6","author":"Moady","year":"2024","journal-title":"Int J Heart Fail"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15161","article-title":"Mortality risk stratification for takotsubo syndrome: evaluating CRP measurement alongside the InterTAK prognostic score","volume":"12","author":"Faucher","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0022","article-title":"Alteration of serum biomarkers in patients with hypertrophic cardiomyopathy with and without atrial fibrillation","volume":"15","author":"Sari","year":"2021","journal-title":"Biomarkers Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004529","article-title":"Prognostic significance of plasma high-sensitivity C-reactive protein in patients with hypertrophic cardiomyopathy","volume":"6","author":"Zhu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030797","article-title":"Chemotherapeutic-induced cardiovascular dysfunction: physiological effects, early detection-the role of telomerase to counteract mitochondrial defects and oxidative stress","volume":"19","author":"Quryshi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15363","article-title":"Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction","volume":"12","author":"Wang","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B225","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12916-025-04301-w","article-title":"The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy: a multicenter randomized study (HYPIC trial)","volume":"23","author":"He","year":"2025","journal-title":"BMC Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03514-2","article-title":"Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis","volume":"19","author":"Malandrino","year":"2024","journal-title":"Intern Emerg Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-021-05040-3","article-title":"Effects of oral colchicine administration as first-line adjunct therapy in myopericarditis","volume":"47","author":"Duran","year":"2022","journal-title":"Herz"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12804","article-title":"Selective C-reactive protein-apheresis in patients","volume":"23","author":"Ries","year":"2019","journal-title":"Ther Apher Dial"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673348789250604113545","article-title":"Inflammatory biomarkers in hypertension","volume":"32","author":"Tsioufis","year":"2025","journal-title":"Curr Med Chem"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2014.04.012","article-title":"Impact of inflammation on vascular disease in hypertension","volume":"78","author":"Virdis","year":"2014","journal-title":"Maturitas"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720984426","article-title":"Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension","volume":"11","author":"Bisaria","year":"2020","journal-title":"J Prim Care Community Health"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.111","article-title":"C-reactive protein and hypertension","volume":"28","author":"Hage","year":"2014","journal-title":"J Hum Hypertens"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.664854","article-title":"C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice","volume":"115","author":"Vongpatanasin","year":"2007","journal-title":"Circulation"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005729","article-title":"The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness","volume":"6","author":"Tomiyama","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B235","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12872-024-03870-7","article-title":"Transgenic human C-reactive protein affects oxidative stress but not inflammation biomarkers in the aorta of spontaneously hypertensive rats","volume":"24","author":"Nemeckova","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.89","article-title":"C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of han chinese","volume":"35","author":"Kong","year":"2012","journal-title":"Hypertens Res"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.03.030","article-title":"Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in turkish adults","volume":"206","author":"Komurcu-Bayrak","year":"2009","journal-title":"Atherosclerosis"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.09.107","article-title":"Association study of CRP gene polymorphism and hypertension in han chinese population","volume":"512","author":"Zhao","year":"2013","journal-title":"Gene"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(03)00566-1","article-title":"High sensitivity c-reactive protein as an independent risk factor for essential hypertension","volume":"16","author":"Chul Sung","year":"2003","journal-title":"Am J Hypertens"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2010.91","article-title":"The relationship between inflammation, obesity and risk for hypertension in the multi-ethnic study of atherosclerosis (MESA)","volume":"25","author":"Lakoski","year":"2011","journal-title":"J Hum Hypertens"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328326f801","article-title":"C-reactive protein implications in new-onset hypertension in a healthy population initially aged 65 years: the proof study","volume":"27","author":"Dauphinot","year":"2009","journal-title":"J Hypertens"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02571-x","article-title":"Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts","volume":"24","author":"Huang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B243","first-page":"97","article-title":"Endothelial dysfunction and inflammation in different stages of essential hypertension","volume":"22","author":"Gupta","year":"2011","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.63.e56489","article-title":"High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations","volume":"63","author":"Gencheva","year":"2021","journal-title":"Folia Med (Plovdiv)"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13050477","article-title":"H-type hypertension and C reactive protein in recurrence of ischemic stroke","volume":"13","author":"Zhang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"B246","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/ajh\/hpw011","article-title":"Prognostic value of C-reactive protein in resistant hypertension","volume":"29","author":"Cortez","year":"2016","journal-title":"Am J Hypertens"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2012.707336","article-title":"Red cell distribution width and inflammation in patients with non-dipper hypertension","volume":"22","author":"\u00d6zcan","year":"2013","journal-title":"Blood Pressure"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.09.010","article-title":"Platelet activation and inflammatory response in patients with non-dipper hypertension","volume":"209","author":"Kaya","year":"2010","journal-title":"Atherosclerosis"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2009.01955.x","article-title":"The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis","volume":"39","author":"Rizzo","year":"2009","journal-title":"Intern Med J"},{"key":"B250","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13128","article-title":"Baseline hs-CRP predicts hypertension remission in metabolic syndrome","volume":"49","author":"Carbone","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"B252","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12872-023-03509-z","article-title":"Hypersensitive C-reactive protein as a potential indicator for predicting left ventricular hypertrophy in elderly community-dwelling patients with hypertension","volume":"23","author":"Song","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1097\/MBP.0000000000000713","article-title":"High-sensitivity C-reactive protein predicts microalbuminuria progression in essential hypertensive patients: a 3-year follow-up study","volume":"29","author":"Yang","year":"2024","journal-title":"Blood Pressure Monit"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12734","article-title":"The relationship between high-sensitivity C-reactive protein levels and left ventricular hypertrophy in patients with newly diagnosed hypertension","volume":"18","author":"Seyfeli","year":"2016","journal-title":"J Clin Hypertens"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-006-0173-2","article-title":"C-reactive protein and incident left ventricular hypertrophy in essential hypertension","volume":"28","author":"Assadi","year":"2007","journal-title":"Pediatr Cardiol"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000147415.40692.7f","article-title":"Low-grade inflammation and microalbuminuria in hypertension","volume":"24","author":"Pedrinelli","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jash.2011.03.004","article-title":"Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults","volume":"5","author":"Amer","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.919506","article-title":"Joint effect of elevated-c-reactive protein level and hypertension on new-onset stroke: a nationwide prospective cohort study of CHARLS","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-026-01118-9","article-title":"C-reactive protein and residual cardiovascular risk in hypertension: a prospective cohort study","volume":"40","author":"Cai","year":"2026","journal-title":"J Hum Hypertens"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2022.2039627","article-title":"Immunomodulatory properties of antihypertensive drugs and digitalis glycosides","volume":"20","author":"Bryniarski","year":"2022","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.2174\/138161212802481282","article-title":"Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation","volume":"18","author":"Di Raimondo","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.5414\/CP203249","article-title":"Effect of perindopril and bisoprolol on IL-2, INF-\u03b3, hs-CRP and T-cell stimulation and correlations with blood pressure in mild and moderate hypertension","volume":"56","author":"Madej","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2010.531837","article-title":"Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (val-mets)","volume":"33","author":"Shishido","year":"2011","journal-title":"Clin Exp Hypertens"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.3390\/nu18010153","article-title":"Synergistic role of aerobic exercise and vitamin C in reducing hypertension and restoring redox-inflammatory balance","volume":"18","author":"Ahmad","year":"2026","journal-title":"Nutrients"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105511","article-title":"Periodontal therapy and treatment of hypertension-alternative to the pharmacological approach. A systematic review and meta-analysis","volume":"166","author":"Sharma","year":"2021","journal-title":"Pharmacol Res"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.03.016","article-title":"Relation of C-reactive protein, fibrinogen, and cardiorespiratory fitness to risk of systemic hypertension in men","volume":"115","author":"Jae","year":"2015","journal-title":"Am J Cardiol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160351.95181.d0","article-title":"Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality","volume":"25","author":"Davey Smith","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.229","article-title":"Co-effect of insulin resistance and biomarkers of inflammation and endothelial dysfunction on hypertension","volume":"35","author":"Li","year":"2012","journal-title":"Hypertens Res"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1475051","article-title":"CRP deposition in human abdominal aortic aneurysm is associated with transcriptome alterations toward aneurysmal pathogenesis: insights from in situ spatial whole transcriptomic analysis","volume":"15","author":"Kim","year":"2024","journal-title":"Front Immunol"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1233807","article-title":"C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms","volume":"14","author":"Fu","year":"2023","journal-title":"Front Immunol"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2017.05.024","article-title":"Serum high-sensitive C-reactive protein level and CRP genetic polymorphisms are associated with abdominal aortic aneurysm","volume":"45","author":"Shangwei","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245361","article-title":"CRP immunodeposition and proteomic analysis in abdominal aortic aneurysm","volume":"16","author":"Kim","year":"2021","journal-title":"PloS One"},{"key":"B274","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.trsl.2025.05.008","article-title":"Multiplexed imaging-driven single-cell analysis of abdominal aortic aneurysm according to C-reactive protein deposition","volume":"282","author":"Kim","year":"2025","journal-title":"Transl Res"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.07.105","article-title":"C-reactive protein polymorphism rs3091244 is associated with abdominal aortic aneurysm","volume":"60","author":"Saratzis","year":"2014","journal-title":"J Vasc Surg"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.07.081","article-title":"C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism","volume":"49","author":"Badger","year":"2009","journal-title":"J Vasc Surg"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2308270","article-title":"Circulating inflammatory mediators and genetic polymorphisms of inflammation mediators and their association with factors related to abdominal aortic aneurysm: a systemic review and meta-analysis","volume":"23","author":"Wang","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2008.11.027","article-title":"Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma","volume":"37","author":"Karlsson","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.09.122","article-title":"C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair","volume":"202","author":"De Haro","year":"2016","journal-title":"Int J Cardiol"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68287","article-title":"Infected abdominal aortic aneurysm successfully treated with endovascular aortic repair and antibiotics: a case report","author":"Nakajima","year":"2024","journal-title":"Cureus"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1315627","article-title":"A case of infective abdominal aortic aneurysm due to haemophilus influenzae type B","volume":"21","author":"Sato","year":"2012","journal-title":"Int J Angiol"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S465873","article-title":"Inflammatory markers and aortic aneurysms: exploring the role of Hs-CRP and MHR in ascending aortic aneurysm development","volume":"17","author":"K\u00f6pr\u00fcl\u00fc","year":"2024","journal-title":"Int J Gen Med"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivs331","article-title":"C-reactive protein\/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms","volume":"15","author":"Artemiou","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-018-1203-8","article-title":"Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases","volume":"33","author":"Kasashima","year":"2018","journal-title":"Heart Vessels"},{"key":"B285","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1155\/2011\/783721","article-title":"MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms\u2013new implication of the old biomarkers","volume":"31","author":"Wiernicki","year":"2011","journal-title":"Dis Markers"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2014.12.006","article-title":"Prospective evaluation of post-implantation inflammatory response after EVAR for AAA: influence on patients\u2019 30 day outcome","volume":"49","author":"Arnaoutoglou","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.05.065","article-title":"Combined cathepsin S and hs-CRP predicting inflammation of abdominal aortic aneurysm","volume":"46","author":"Qin","year":"2013","journal-title":"Clin Biochem"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051182","article-title":"Association of IL-10 and CRP with pulse wave velocity in patients with abdominal aortic aneurysm","volume":"11","author":"\u00c5str\u00f6m Malm","year":"2022","journal-title":"J Clin Med"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2017.06.090","article-title":"Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms","volume":"67","author":"Moxon","year":"2018","journal-title":"J Vasc Surg"},{"key":"B290","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12933-025-02600-3","article-title":"The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B291","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13063-023-07461-3","article-title":"Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial","volume":"24","author":"Li","year":"2023","journal-title":"Trials"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1177\/17085381251379296","article-title":"The role of doxycycline in reducing MMP-9 and acute-phase reactants to limit abdominal aortic aneurysm growth: a systematic review","volume":"34","author":"Morales-Ojeda","year":"2026","journal-title":"Vascular"},{"key":"B293","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"JAMA"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.125.322601","article-title":"Sex-specific risk of smoking for abdominal aortic aneurysm and exploration of potential mechanism: meta-analysis and prospective cohort study","volume":"45","author":"Welsh","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1177\/15266028211065966","article-title":"Factors associated with noninfectious fever after endovascular aortic aneurysm repair","volume":"29","author":"Nana","year":"2022","journal-title":"J Endovasc Ther Off J Int Soc Endovasc Spec"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.244124","article-title":"Plasma C-reactive protein and abdominal aortic aneurysm: a mendelian randomization analysis","volume":"131","author":"Qin","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"B299","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jamacardio.2025.4491","article-title":"Rationale, design, and baseline clinical characteristics of the ziltivekimab cardiovascular outcomes trial: interleukin-6 inhibition and atherosclerotic event rate reduction","volume":"11","author":"Ridker","year":"2026","journal-title":"JAMA Cardiol"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.591714","article-title":"C-reactive protein apheresis as anti-inflammatory therapy in acute myocardial infarction: results of the CAMI-1 study","volume":"8","author":"Ries","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100349","article-title":"Anti-monomeric C-reactive protein antibody ameliorates arthritis and nephritis in mice","volume":"207","author":"Fujita","year":"2021","journal-title":"J Immunol"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1924339\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:04:09Z","timestamp":1787655849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1924339\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":302,"alternative-id":["10.3389\/fimmu.2026.1924339"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1924339","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1924339"}}